Medical Innovation Act: Funding Research from Drug Company Penalties.
This act aims to boost funding for medical research. Money will come from additional payments imposed on large pharmaceutical companies that profit significantly from drugs developed with public investment and have also entered into legal settlements for violations. This initiative seeks to accelerate the development of new drugs and therapies, especially in areas lacking effective solutions.
Key points
Pharmaceutical companies selling drugs with over a billion dollars in annual sales, partly developed with public funds, will face additional payments.
These payments apply if the company has high net income and has entered into a legal settlement of at least one million dollars for regulatory violations.
Collected funds will go to medical research by the FDA and NIH, focusing on urgent needs and innovation.
The act supports research into diseases lacking effective treatments and promotes early career scientists.
Status:
Expired
Civic Will
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.